Home VB Group Interview Episode 12 Preview: Li Bin, Founder of Huitai Kangming Biotech, to Share Insights on Internet Healthcare’s Unresolved Challenges

VB Group Interview Episode 12 Preview: Li Bin, Founder of Huitai Kangming Biotech, to Share Insights on Internet Healthcare’s Unresolved Challenges

Oct 12, 2015 08:00 CST Updated 08:00

untitled

[“VB Group Interview” Focused on Essential Insights] This Wednesday at 8:00 PM, join us for the 12th episode of “VB Group Interview,” featuring a lecture by Mr. Li Bin! [This Issue's Theme]Internet HealthcareTwo Unresolvable Issues 【Keynote Speaker】Li Bin, Founder of Huitai Kangming Biotechnology [Chat Time] October 14, 2015, 8:00 PM - 9:30 PM [Chat Location] VCBeat WeChat Group [Guest Profile] Li Bin, Founder and CEO of Huitai Kangming Biotechnology, is primarily engaged in the innovation and R&D of new targets, novel structures, and new drugs based on combinatorial chemistry for Class I innovative drugs. He is a member of the Precision Medicine Group at Lawrence Berkeley National Laboratory and one of the initiators of the Scientific Discourse Series at Jin Yong Academy.  

To participate in this VBInsight group interview

Please scan the QR code below!!!

 
untitled1